Abstract
Sila-substitution (C/Si exchange) of one or both of the two quaternary carbon atoms of the histaminic H1 antagonist terfenadine (1a) leads to sila-terfenadine-A (1b; R3COH → R3SiOH), sila-terfenadine-B (1c; R4C → R4Si), or disila-terfenadine (1d; R3COH → R3SiOH, R4C → R4Si). Sila-substitution of the quaternary carbon atom of the histaminic H1 antagonist fexofenadine (2a) affords sila-fexofenadine (2b; R3COH → R3SiOH). The silicon compounds rac-1b, rac-1c, rac-1d, and rac-2b were synthesized in multistep syntheses, and the identities of these compounds and their precursors were established by elemental analyses and multinuclear NMR studies. Some of the precursors were additionally characterized by single-crystal X-ray diffraction. The pharmacological profiles of rac-1a, rac-1b, rac-1c, rac-1d, rac-2a, and rac-2b were assessed across a range of histaminic receptor binding assays (radioligand binding studies at histamine central H1, peripheral H1, H2, and H3 receptors). The silicon compounds, within experimental error, exhibited an affinity and selectivity profile similar to their corresponding carbon analogues.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
